Beloo Mirakhur
- Immunology and Allergy top 2%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 14
- Lung Cancer Research Studies 13
- Immunology top 5%
- Dermatology top 2%
-
- Neuroendocrine Tumor Research Advances 21
-
- Neuroblastoma Research and Treatments 15
-
- Melanoma and MAPK Pathways 6
-
- Pituitary Gland Disorders and Treatments 4
- Growth Hormone and Insulin-like Growth Factors 4
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Tina HatleyThomas A.E. Platts‐MillsDavid MauroDiane R. GoldShama M. SatinoverJacob D. HosenBarbara A. MurphyEmily Chan
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (12 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Beloo Mirakhur
49 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology and Allergy 343
- Oncology 848
- Immunology 488
- Dermatology 178
- Radiology, Nuclear Medicine and Imaging 453
Countries citing papers authored by Beloo Mirakhur
This map shows the geographic impact of Beloo Mirakhur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beloo Mirakhur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beloo Mirakhur more than expected).
Fields of papers citing papers by Beloo Mirakhur
This network shows the impact of papers produced by Beloo Mirakhur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beloo Mirakhur. The network helps show where Beloo Mirakhur may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beloo Mirakhur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 11 | |
| 3 | 2020 | 8 | |
| 4 | 2019 | 8 | |
| 5 | 2019 | 199 | |
| 6 | 2019 | 3 | |
| 7 | 2019 | 21 | |
| 8 | 2018 | 5 | |
| 9 | 2018 | 7 | |
| 10 | 2018 | 4 | |
| 11 | 2018 | 10 | |
| 12 | 2017 | 8 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 9 | |
| 15 | 2016 | 1 | |
| 16 | 2014 | 37 | |
| 17 | 2013 | 1 | |
| 18 | 2009 | 147 | |
| 19 | Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactosebreakdown → | 2008 | 1075 |
| 20 | 2004 | 17 |
About Beloo Mirakhur
Beloo Mirakhur is a scholar working on Oncology, Neurology and Epidemiology, having authored 50 papers that have together received 2.1k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (21 papers), Neuroblastoma Research and Treatments (15 papers), Pancreatic and Hepatic Oncology Research (14 papers), Lung Cancer Research Studies (13 papers), Melanoma and MAPK Pathways (6 papers), Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Immunology and Allergy (343 citations), Oncology (848 citations) and Immunology (488 citations). Beloo Mirakhur has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Tina Hatley, Thomas A.E. Platts‐Mills, David Mauro, Diane R. Gold, Shama M. Satinover, Jacob D. Hosen, Barbara A. Murphy, Emily Chan, Robbert J.C. Slebos and Christine H. Chung. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.